Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on VRX
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Valeant Pharmaceuticals International (NY:VRX)
Delayed:
74.67
-0.15 (0.2%)
Trade Now!
Previous Close
$74.82
52 Week High
$78.69
Open
$74.78
52 Week Low
$42.47
Day High
$74.89
P/E
N/A
Day Low
$73.86
EPS
$0.00
Volume
652,291
Friends, Peers and Foes
(?)
:
ACT
,
OMPI
,
MRX
,
WCRX
,
MYL
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 21, 2013 05:10 PM
Form 8-K Valeant Pharmaceuticals For: May 21
May 21, 2013 05:00 PM
Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
May 20, 2013 05:00 PM
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
May 20, 2013 11:01 AM
UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
May 20, 2013 07:16 AM
Valeant (VRX), Mylan (MYL) on Watch as Actavis (ACT) Buys Warner Chilcott (WCRX)
May 17, 2013 01:50 PM
UPDATE: Correct: Buying Warner Chilcott plc (WCRX) Seen as Takeover Defense by Actavis (ACT)
May 16, 2013 06:05 AM
Form 8-K Valeant Pharmaceuticals For: May 15
May 15, 2013 08:15 PM
Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors
May 14, 2013 05:20 PM
Mandel's Lone Pine Capital Enters H&R Block (HRB), CME (CME), Valeant (VRX); Liquidates Facebook (FB)
May 14, 2013 04:06 PM
Form 8-K Valeant Pharmaceuticals For: May 08
View All Articles
May 2, 2013 06:28 AM
Valeant Pharma (VRX) Reports Q1 EPS of $1.30; Boosts FY13 EPS Outlook
Apr 26, 2013 07:28 PM
Valeant Pharmaceuticals (VRX) Near Deal to Acquire Actavis (ACT) for Over $13B
Apr 4, 2013 08:03 AM
Valeant Pharma (VRX) Updates on Generic Zovirax Approval; Sees Cash EPS Impact
Apr 3, 2013 08:04 AM
Valeant Pharmaceuticals (VRX) Raises Offer for Obagi Medical (OMPI) to $24/Sh
Mar 20, 2013 08:02 AM
Valeant Pharma (VRX) to Acquire Obagi Medical (OMPI) for $19.75/Share
Feb 28, 2013 06:47 AM
Valeant Pharmaceuticals (VRX) Improves Q4 EPS to $1.34
Nov 2, 2012 06:03 AM
Valeant Pharma (VRX) Reports Q3 EPS of $1.15; Narrows Q4, FY12 EPS Outlook
Sep 4, 2012 06:29 AM
Valeant (VRX) to Acquire Medicis (MRX) to $44/Share; Deal Valued at $2.6B
Aug 2, 2012 07:33 AM
Valeant Pharmaceuticals International, Inc. (VRX) Reports Q2 Earnings of $1.01; Guides Slightly Higher
May 3, 2012 08:10 AM
Valeant Pharmaceuticals (VRX) Posts Q1 EPS of 99c; Boosts FY12 Outlook
View All Major News
May 20, 2013 11:01 AM
UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
May 20, 2013 07:16 AM
Valeant (VRX), Mylan (MYL) on Watch as Actavis (ACT) Buys Warner Chilcott (WCRX)
May 17, 2013 01:50 PM
UPDATE: Correct: Buying Warner Chilcott plc (WCRX) Seen as Takeover Defense by Actavis (ACT)
May 14, 2013 05:20 PM
Mandel's Lone Pine Capital Enters H&R Block (HRB), CME (CME), Valeant (VRX); Liquidates Facebook (FB)
May 14, 2013 01:34 PM
Warner Chilcott (WCRX) Volatile as Actavis (ACT) Has a New Bidder
May 10, 2013 12:35 PM
Streetinsider.com's Hot Lunchtime Reads 05/10: (WCRX) (AMRN) ((NVDA) (TSLA) (DIS)
May 10, 2013 12:12 PM
Valeant (VRX) Volatile as Actavis (ACT) Seeks Its Own Deal
May 10, 2013 12:09 PM
Actavis (ACT) Said to be in Talks to Acquire Warner Chilcott (WCRX)
May 2, 2013 06:28 AM
Valeant Pharma (VRX) Reports Q1 EPS of $1.30; Boosts FY13 EPS Outlook
May 1, 2013 05:47 PM
Trading Radar for 05/02: MGM Resorts (MGM), GM (GM), Kraft Foods (KRFT), athenahealth (ATHN) Report
View All Reports
May 21, 2013 05:00 PM
Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
May 20, 2013 05:00 PM
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
May 15, 2013 08:15 PM
Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors
May 13, 2013 05:00 PM
Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
May 10, 2013 05:00 PM
Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
May 2, 2013 08:14 PM
Valeant Pharmaceuticals Provides Efinconazole Update
May 2, 2013 09:01 AM
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
May 2, 2013 06:00 AM
Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results
May 1, 2013 08:01 AM
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
May 1, 2013 08:01 AM
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
View All Press Releases
May 21, 2013 05:10 PM
Form 8-K Valeant Pharmaceuticals For: May 21
May 16, 2013 06:05 AM
Form 8-K Valeant Pharmaceuticals For: May 15
May 14, 2013 04:06 PM
Form 8-K Valeant Pharmaceuticals For: May 08
May 3, 2013 12:33 PM
Form 10-Q Valeant Pharmaceuticals For: Mar 31
May 2, 2013 06:31 AM
Form 8-K Valeant Pharmaceuticals For: May 02
Apr 23, 2013 02:51 PM
Form 4 Valeant Pharmaceuticals For: Apr 20 Filed by: Schiller Howard Bradley
Apr 23, 2013 02:24 PM
Form 4 Valeant Pharmaceuticals For: Apr 20 Filed by: Kornwasser Laizer
Apr 2, 2013 05:56 PM
Form 4 Valeant Pharmaceuticals For: Mar 31 Filed by: Farmer Ronald Harold
Apr 2, 2013 05:33 PM
Form 4 Valeant Pharmaceuticals For: Mar 31 Filed by: Provencio Norma Ann
Apr 2, 2013 05:23 PM
Form 4 Valeant Pharmaceuticals For: Mar 31 Filed by: MELAS KYRIAZI THEO
View All Filings
Entities mentioned with
VRX
Earnings
|
View Related Stories »
Valeant Pharmaceuticals/Biovail Merger
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Dividend
|
View Related Stories »
Citi
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
UBS
|
View Related Stories »
JPMorgan
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Valeant Pharmaceuticals/Cephalon, Inc.
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Bank of America
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Notable Mergers and Acquisitions
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Lazard
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Barclays
|
View Related Stories »
Soleil Securities
|
View Related Stories »
Hedge Funds
|
View Related Stories »
Trading Radar
|
View Related Stories »
Susquehanna International Group of Companies
|
View Related Stories »
Cowen & Co
|
View Related Stories »
Tesla
|
View Related Stories »
Show More...
View All Entities